Low galectin-3 capacity to discriminate thyroid lesions;Baja capacidad de galectina-3 para discriminar lesiones tiroideas

Revista de Investigacion Clinica

Volumn 56, Issue 5, 2004, Pages 623-628

  De León Mazariegos, Romulo ^a   Canedo Patzi, Marcela ^a   Pérez Enríquez, Bernardo ^a   Candanedo Gonzalez, Fernando ^a   Saqui Salces, Milena ^a   Gamboa Domínguez, Armando ^a   Rull Rodrigo, Juan A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Galectin 3; ROC curve; Sensibility; Specificity; Thyroid

Indexed keywords

GALECTIN 3;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GOITER; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PREDICTION; PROTEIN EXPRESSION; SENSITIVITY AND SENSIBILITY; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

CARCINOMA, PAPILLARY, FOLLICULAR; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; GALECTIN 3; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID NEOPLASMS;

EID: 12444271300     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gamboa-Domínguez A, Candanedo-González F, Uribe-Uribe N, Angeles-Angeles A. Tall cell variant of papillary thyroid carcinoma. A cytohistologic correlation. Acta Cytol 1997; 41: 672-6.
2. López LH, Canto JA, Herrera MF, Gamboa-Domínguez A, Rivera R, González O, et al. Efficacy of fine-needle aspiration biopsy of thyroid nodules: experience of a Mexican institution. World J Surg 1997; 21: 408-11.
3. Gamboa-Domínguez A, Vieitez-Martínez I, Barredo-Prieto B, Richaud-Patin I, Herrera MF, Angeles-Angeles A. Macrofollicular variant of papillary thyroid carcinoma: a case and control analysis. Endocrine Pathol 1996; 7: 303-8.
4. Bernet V, Anderson J, Yashesh V, Salomon B, Adair C, Saji M, et al. Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription polymerasa chain reaction. J Clin Endocr Metab 2002; 87: 4792-7.
5. Inohora H, Yuichiro H, Tadashi Y, Shiro A, Jun-ichi Y, Kenji H, et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 1999; 85: 2475-84.
6. Pricci F, Gaetano L, Amadio L, Iacobini C, Romeo G, Cornone S, et al. Role of galectin-3 as a receptor for advanced glycosylation end products. Kidney Int 2000; 58: S31-S39.
7. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-50.
8. Saggiorato E, Cappia S, De Giuli P, Mussa AI, Pancani G, Caraci P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocr Metab 2001; 86: 5152-8.
9. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well differentiated carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002; 40: 80-7.
10. Gaffney R, Carney A, Sebo T, Erickson L, Volante M, Papotti M, et al. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. Am J Surg Pathol 2003; 27: 494-8.
11. Davies R, Dina R, Miac R. Galectin-3 in thyroid nodules: a cytohistological correlation. Cytopathology 2003; 14S: 1-9.
12. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S. et al. Galectin 3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998; 58: 3015-20.
13. Xu XC, AK el-Naggar, R Lotan. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 1995; 147: 815-21.
14. Fernández P, Merino M, Gómez M, Campo E, Medina T, Castronovo V, et al. Galectin-3 and laminin expression neoplastic and non neoplastic thyroid tissue. J Pathol 1997; 181: 80-6.
15. Herrmann M, LiVolsi V, Phasa T, Roberts S, Wojcik E, Baloch Z. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 2003; 126: 710-13.
16. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 1998; 18: 2637-41.
17. Greene FL, Page DL, Fleming ID, Fritz AG, Balch Ch M, Haller DG, Morrow M, editors. AJCC Cancer staging manual. 6th Ed. New York: Springer; 2002.
18. Herrera MF, López-Graniel CM, Saldaña J, Gamboa-Domínguez A, Richaud-Patin Y, Vargas-Vorackova F, et al. Papillary thyroid carcinoma in Mexican patients: clinical aspects and prognostic factors. World J Surg 1996; 20: 94-100.
19. Jakubiak-Wielganowicz M, Kubiak R, Sygut J, Pomorski L, Kordek R. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. Pol J Pathol 2003; 54: 111-5.
20. Kovacs RB, Foldes J, Winkler G, Bodo M, Sapi Z. The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol 2003; 149: 449-53.
21. Feilchenfeldt J, Tötsch M, Sep SY, Robert J, Spiliopoulos A, Frilling A, et al. Expression of galectina-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol 2003; 16: 1117-23.